Leuprorelin (Lucrin Depot 3-month) inj 11.25 mg: Supply issue

Supply issue Active

The supplier of Lucrin injections have advised that there's been a delay to their latest shipment of the 3-month depot product (Pharmacode 2330156)

Affected product

Leuprorelin 

  • Presentation: Inj 11.25 mg prefilled dual chamber syringe 
  • Brand: Lucrin Depot 3-month
  • Pharmacode: 2330156 

Note this product is partially funded, unless the patient is a child or adolescent who cannot tolerate goserelin. 

The inj 3.75 mg presentation is unaffected by this supply issue.

Schedule listing for leuprorelin(external link)

Expected resupply late September 2022

We expect that normal supply of this medicine will resume in late September 2022.

Alternative treatment

Patients who cannot access the 3-monthly injection, should talk to a health care professional about whether the Lucrin 1-month depot is a suitable alternative.

Leuprorelin monograph in the NZ Formulary(external link)

We acknowledge that monthly injections are not ideal. Supply chain issues are affecting a range of products, we expect this issue will be resolved by the end of September. 

Who to contact

For any enquiries about Lucrin, contact AbbVie Medical Information on 0800 900 030 or by email at medinfoanz@abbvie.com

If you have questions about the funding for this product, email enquiry@pharmac.govt.nz

Please include as much information as you can about the product (presentation, brand, pharmacode) and who your wholesaler is.

About Pharmac's role in supply management